EP0513000A4 - Ameloration d'images d'irm d'os et de tissus apparentes a l'aide de complexes de cations paramagnetiques et de ligands de polyphosphonate. - Google Patents
Ameloration d'images d'irm d'os et de tissus apparentes a l'aide de complexes de cations paramagnetiques et de ligands de polyphosphonate.Info
- Publication number
- EP0513000A4 EP0513000A4 EP19900917189 EP90917189A EP0513000A4 EP 0513000 A4 EP0513000 A4 EP 0513000A4 EP 19900917189 EP19900917189 EP 19900917189 EP 90917189 A EP90917189 A EP 90917189A EP 0513000 A4 EP0513000 A4 EP 0513000A4
- Authority
- EP
- European Patent Office
- Prior art keywords
- bone
- complexes
- image enhancement
- mri image
- related tissue
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 210000000988 bone and bone Anatomy 0.000 title abstract 3
- 150000001768 cations Chemical class 0.000 title abstract 2
- 239000003446 ligand Substances 0.000 title abstract 2
- 230000005298 paramagnetic effect Effects 0.000 title abstract 2
- 210000001519 tissue Anatomy 0.000 title 1
- -1 dihydroxyphosphorylmethyl Chemical group 0.000 abstract 2
- ABLZXFCXXLZCGV-UHFFFAOYSA-N Phosphorous acid Chemical group OP(O)=O ABLZXFCXXLZCGV-UHFFFAOYSA-N 0.000 abstract 1
- 125000000217 alkyl group Chemical group 0.000 abstract 1
- 125000003277 amino group Chemical group 0.000 abstract 1
- 125000003118 aryl group Chemical group 0.000 abstract 1
- 239000003795 chemical substances by application Substances 0.000 abstract 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 abstract 1
- 239000002184 metal Substances 0.000 abstract 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01R—MEASURING ELECTRIC VARIABLES; MEASURING MAGNETIC VARIABLES
- G01R33/00—Arrangements or instruments for measuring magnetic variables
- G01R33/20—Arrangements or instruments for measuring magnetic variables involving magnetic resonance
- G01R33/44—Arrangements or instruments for measuring magnetic variables involving magnetic resonance using nuclear magnetic resonance [NMR]
- G01R33/48—NMR imaging systems
- G01R33/54—Signal processing systems, e.g. using pulse sequences ; Generation or control of pulse sequences; Operator console
- G01R33/56—Image enhancement or correction, e.g. subtraction or averaging techniques, e.g. improvement of signal-to-noise ratio and resolution
- G01R33/5601—Image enhancement or correction, e.g. subtraction or averaging techniques, e.g. improvement of signal-to-noise ratio and resolution involving use of a contrast agent for contrast manipulation, e.g. a paramagnetic, super-paramagnetic, ferromagnetic or hyperpolarised contrast agent
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K49/00—Preparations for testing in vivo
- A61K49/06—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/6524—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having four or more nitrogen atoms as the only ring hetero atoms
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Physics & Mathematics (AREA)
- General Health & Medical Sciences (AREA)
- Radiology & Medical Imaging (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Signal Processing (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- High Energy & Nuclear Physics (AREA)
- Condensed Matter Physics & Semiconductors (AREA)
- General Physics & Mathematics (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US44114489A | 1989-11-27 | 1989-11-27 | |
US441144 | 1989-11-27 | ||
PCT/US1990/005967 WO1991007911A1 (fr) | 1989-11-27 | 1990-10-17 | Ameloration d'images d'irm d'os et de tissus apparentes a l'aide de complexes de cations paramagnetiques et de ligands de polyphosphonate |
Publications (3)
Publication Number | Publication Date |
---|---|
EP0513000A4 true EP0513000A4 (fr) | 1992-09-01 |
EP0513000A1 EP0513000A1 (fr) | 1992-11-19 |
EP0513000B1 EP0513000B1 (fr) | 1996-07-31 |
Family
ID=23751720
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP90917189A Expired - Lifetime EP0513000B1 (fr) | 1989-11-27 | 1990-10-17 | Ameloration d'images d'irm d'os et de tissus apparentes a l'aide de complexes de cations paramagnetiques et de ligands de polyphosphonate |
Country Status (10)
Country | Link |
---|---|
EP (1) | EP0513000B1 (fr) |
JP (1) | JP2593963B2 (fr) |
AT (1) | ATE140869T1 (fr) |
AU (1) | AU649001B2 (fr) |
CA (1) | CA2069638C (fr) |
DE (1) | DE69028001T2 (fr) |
DK (1) | DK0513000T3 (fr) |
ES (1) | ES2091251T3 (fr) |
GR (1) | GR3020861T3 (fr) |
WO (1) | WO1991007911A1 (fr) |
Families Citing this family (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5885549A (en) * | 1991-02-01 | 1999-03-23 | Imarx Pharmaceutical Corp. | Phosphorylated materials as contrast agents for use in magnetic resonance imaging of the gastrointestinal region |
US5143716A (en) * | 1991-02-01 | 1992-09-01 | Unger Evan C | Phosphorylated sugar alcohols, Mono- and Di-Saccharides as contrast agents for use in magnetic resonance imaging of the gastrointestinal region |
MX9207168A (es) * | 1991-12-10 | 1993-12-01 | Dow Chemical Co | Composiciones orales para inhibir la formacion de placa y de calculos. |
US5555884A (en) * | 1992-12-16 | 1996-09-17 | Kabushiki Kaisha Egawa | Measuring method by using resonance of a resonance medium |
US5714604A (en) * | 1993-05-06 | 1998-02-03 | The Dow Chemical Company | Process for the preparation of azamacrocyclic or acyclic aminophosphonate ester derivatives |
US5409689A (en) * | 1993-08-13 | 1995-04-25 | Concat, Ltd. | MRI image enhancement using complexes of paramagnetic cations and amine ligands containing a mixture of phosphonate and non-phosphonate pendant arms |
US5834456A (en) * | 1996-02-23 | 1998-11-10 | The Dow Chemical Company | Polyazamacrocyclofluoromonoalkylphosphonic acids, and their complexes, for use as contrast agents |
US6093382A (en) | 1998-05-16 | 2000-07-25 | Bracco Research Usa Inc. | Metal complexes derivatized with folate for use in diagnostic and therapeutic applications |
US6565828B2 (en) * | 2000-04-07 | 2003-05-20 | Bristol-Myers Squibb Company | Macrocyclic chelants for metallopharmaceuticals |
EP1637524A1 (fr) * | 2004-09-20 | 2006-03-22 | Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. | Dérivés de 1-, 4, 7,-tris (carboxymethyl)-1,4,7,10-tetraazacyclo-dodecane 10-substitués utilisables comme agents de contraste |
JP5690733B2 (ja) * | 2009-08-20 | 2015-03-25 | 富士フイルムRiファーマ株式会社 | ビスホスホン酸誘導体及びその放射性金属核種標識体 |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0258616A1 (fr) * | 1986-08-04 | 1988-03-09 | Salutar, Inc. | Imagerie RMN avec des sels de métaux polyvalents paramagnétiques de poly-(acide-alkylène-amino)-alcanes |
EP0382582A1 (fr) * | 1989-02-10 | 1990-08-16 | Celltech Therapeutics Limited | Tetra-aza macrocycles et leurs procédés de préparation |
EP0404605A2 (fr) * | 1989-06-23 | 1990-12-27 | Celltech Therapeutics Limited | Tri-aza-macrocycles et leurs procédés de préparation |
EP0468634A1 (fr) * | 1990-06-18 | 1992-01-29 | The Dow Chemical Company | Utilisation de complexes macrocycliques aminophosphoniques acides comme agents d'imagerie |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4515766A (en) * | 1980-06-23 | 1985-05-07 | The Massachusetts General Hospital | Labeled phosphonic acid compositions for investigations of in vivo deposits of calcium |
DE3129906C3 (de) * | 1981-07-24 | 1996-12-19 | Schering Ag | Paramagnetische Komplexsalze, deren Herstellung und Mittel zur Verwendung bei der NMR-Diagnostik |
US4647447A (en) * | 1981-07-24 | 1987-03-03 | Schering Aktiengesellschaft | Diagnostic media |
DE3237573A1 (de) * | 1982-10-09 | 1984-04-12 | Hoechst Ag, 6230 Frankfurt | Technetium-99m-tri- und tetraphosphonate zur szintigraphischen dastellung res-haltiger organe und der lymphgefaesse und verfahren zu deren herstellung |
FR2550449B1 (fr) * | 1983-08-12 | 1986-01-31 | Commissariat Energie Atomique | Agents de relaxation specifiques d'organes ou de pathologies, utilisables pour modifier les contrastes en imagerie medicale par resonance magnetique nucleaire |
US4749560A (en) * | 1984-08-13 | 1988-06-07 | Research Corporation | Metal organo phosphorous compounds for NMR analysis |
US4735210A (en) * | 1985-07-05 | 1988-04-05 | Immunomedics, Inc. | Lymphographic and organ imaging method and kit |
GB8518300D0 (en) * | 1985-07-19 | 1985-08-29 | Amersham Int Plc | Contrast agent |
GB8701054D0 (en) * | 1987-01-16 | 1987-02-18 | Amersham Int Plc | Contrast agent for nmr scanning |
-
1990
- 1990-10-17 JP JP2515855A patent/JP2593963B2/ja not_active Expired - Fee Related
- 1990-10-17 AT AT90917189T patent/ATE140869T1/de not_active IP Right Cessation
- 1990-10-17 DE DE69028001T patent/DE69028001T2/de not_active Expired - Fee Related
- 1990-10-17 WO PCT/US1990/005967 patent/WO1991007911A1/fr active IP Right Grant
- 1990-10-17 DK DK90917189.4T patent/DK0513000T3/da active
- 1990-10-17 EP EP90917189A patent/EP0513000B1/fr not_active Expired - Lifetime
- 1990-10-17 AU AU67322/90A patent/AU649001B2/en not_active Ceased
- 1990-10-17 CA CA002069638A patent/CA2069638C/fr not_active Expired - Fee Related
- 1990-10-17 ES ES90917189T patent/ES2091251T3/es not_active Expired - Lifetime
-
1996
- 1996-08-22 GR GR960402218T patent/GR3020861T3/el unknown
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0258616A1 (fr) * | 1986-08-04 | 1988-03-09 | Salutar, Inc. | Imagerie RMN avec des sels de métaux polyvalents paramagnétiques de poly-(acide-alkylène-amino)-alcanes |
EP0382582A1 (fr) * | 1989-02-10 | 1990-08-16 | Celltech Therapeutics Limited | Tetra-aza macrocycles et leurs procédés de préparation |
EP0404605A2 (fr) * | 1989-06-23 | 1990-12-27 | Celltech Therapeutics Limited | Tri-aza-macrocycles et leurs procédés de préparation |
EP0468634A1 (fr) * | 1990-06-18 | 1992-01-29 | The Dow Chemical Company | Utilisation de complexes macrocycliques aminophosphoniques acides comme agents d'imagerie |
Non-Patent Citations (3)
Title |
---|
CHEMICAL ABSTRACTS, vol. 111, 1989, page 784, abstract no. 194870n, Columbus, Ohio, US; T.Ya. MEDVED et al.: "New cyclopendant organophosphorus complexons: 1,4,7-tris(beta-dihydroxyphosphorylethyl)-1,4,7-triazacylononane", & IZV. AKAD. NAUK SSSR, SER. KHIM. 1988, (9), 2107-13 * |
CHEMICAL ABSTRACTS, vol. 112, 1990, page 732, abstract no. 198536b, Columbus, Ohio, US; Yu.M. POLIKARPOV et al.: "A new cyclopendant organophosphorus complexon: 1,4,7,10-tetrakis(beta-dihydroxyphosphorylethyl)-1,4,7,10-tetraazacylododecane", & IZV. AKAD. NAUK SSSR, SER. KHIM. 1989, (9), 2112-16 * |
MAGNETIC RESONANCE IN MEDICINE, vol. 15, no. 1, July 1990, pages 25-32, Academic Press, Duluth, MN, US; D.C. BUSTER et al.: "Tm(DOTP)5-:A23Na+shift agent for perfused rat hearts" * |
Also Published As
Publication number | Publication date |
---|---|
ES2091251T3 (es) | 1996-11-01 |
CA2069638C (fr) | 1999-02-09 |
CA2069638A1 (fr) | 1991-05-28 |
GR3020861T3 (en) | 1996-11-30 |
WO1991007911A1 (fr) | 1991-06-13 |
AU649001B2 (en) | 1994-05-12 |
DE69028001D1 (de) | 1996-09-05 |
DE69028001T2 (de) | 1996-12-19 |
ATE140869T1 (de) | 1996-08-15 |
DK0513000T3 (da) | 1996-12-30 |
JPH05504127A (ja) | 1993-07-01 |
AU6732290A (en) | 1991-06-26 |
EP0513000A1 (fr) | 1992-11-19 |
EP0513000B1 (fr) | 1996-07-31 |
JP2593963B2 (ja) | 1997-03-26 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE262329T1 (de) | Formulierungen und verfahren zur verminderung der toxizität von anti-neoplastischen mitteln | |
FI911319A0 (fi) | Polypeptidderivat. | |
FI922151A (fi) | Metall-peptidkompositioner och metoder foer stimulering av haortillvaext. | |
ATE170077T1 (de) | Verfahren zur behandlung von krebs durch kombinationstherapie mit 2'- halomethylidenderivaten und einem s- oder m-phase spezifischen antineoplastischen wirkstoff | |
ATE212846T1 (de) | Bisphosphonat und anti-resorption agentien, enthaltende zusammensetzungen zur hemmung der knochenschwund | |
EP0513000A4 (fr) | Ameloration d'images d'irm d'os et de tissus apparentes a l'aide de complexes de cations paramagnetiques et de ligands de polyphosphonate. | |
KR910700073A (ko) | 마크로사이클릭 아미노포스폰산 착화합물, 그의 제조방법, 이를 포함하는 배합물 및 용도 | |
ATE235921T1 (de) | Phosphonate- und nicht-phosphonate einheiten enthaltende polyamino-paramagnetische-chelate fuer anwendung in mri | |
FI895141A0 (fi) | Kelatmedel med orto-ligerande funktionalitet och deras komplexer. | |
FI101597B1 (fi) | Menetelmä kylmäkuivatun koostumuksen valmistamiseksi käytettäväksi potilaan valodynaamisessa hoidossa tai diagnosoinnissa | |
ZA81927B (en) | Phenylpiperazine derivatives of 1,3,4-oxadiazolyphenols their preparation and therapeutic agents containing these compounds | |
FI902901A0 (fi) | Dibenzol/1,5/dioxocin-5-one-derivat, deras anvaendning i laekemedel och foerfarande foer deras framstaellning. | |
DK601888A (da) | Anvendelse af 2-pyrimidinyl-1-piperazinderivater | |
EP0365956A3 (fr) | Agents carcinostatiques | |
ATE147978T1 (de) | Verwendung von (e) - 2 - (p -fluorophenethyl)- 3 - fluoroallylamine zur behandlung der alzheimerschen krankheit | |
RU92016532A (ru) | Бензохиназолиновые соединения, способ их получения, фармацевтическая композиция и способ лечения | |
IT1242026B (it) | Composizione farmaceutica contenente un complesso ferro-schizokinene per il trattamento dell'anemia ferropenica. | |
ATE96035T1 (de) | Verwendung eines polypeptides mit gammainterferon-aktivitaet zur herstellung von pharmazeutischen zusammensetzungen zur behandlung von primitivem pleura-krebs. | |
ATE74770T1 (de) | Tc-99m-w-alkylphosphinico-1-hydroxyalkan-1,1diphosphonate enthaltende praeparate zur knochenszintigraphie sowie verfahren zur herstellung dieser praeparate. | |
EP0480458A3 (en) | Process for the preparation of pharmaceutical compositions containing viminol useful in the treatment of drug dependences | |
GB8810128D0 (en) | Phospholipids & their use as magnetic resonance imaging contrast agents | |
FI964849A0 (fi) | Pyridyylibisfosfonaatit käytettäväksi terapeuttisina aineena |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
17P | Request for examination filed |
Effective date: 19920618 |
|
AK | Designated contracting states |
Kind code of ref document: A1 Designated state(s): AT BE CH DE DK ES FR GB GR IT LI LU NL SE |
|
17Q | First examination report despatched |
Effective date: 19940502 |
|
GRAH | Despatch of communication of intention to grant a patent |
Free format text: ORIGINAL CODE: EPIDOS IGRA |
|
GRAH | Despatch of communication of intention to grant a patent |
Free format text: ORIGINAL CODE: EPIDOS IGRA |
|
GRAA | (expected) grant |
Free format text: ORIGINAL CODE: 0009210 |
|
AK | Designated contracting states |
Kind code of ref document: B1 Designated state(s): AT BE CH DE DK ES FR GB GR IT LI LU NL SE |
|
REF | Corresponds to: |
Ref document number: 140869 Country of ref document: AT Date of ref document: 19960815 Kind code of ref document: T |
|
REG | Reference to a national code |
Ref country code: CH Ref legal event code: NV Representative=s name: KIRKER & CIE SA |
|
ITF | It: translation for a ep patent filed |
Owner name: ING. A. GIAMBROCONO & C. S.R.L. |
|
REF | Corresponds to: |
Ref document number: 69028001 Country of ref document: DE Date of ref document: 19960905 |
|
ET | Fr: translation filed | ||
REG | Reference to a national code |
Ref country code: GR Ref legal event code: FG4A Free format text: 3020861 |
|
REG | Reference to a national code |
Ref country code: ES Ref legal event code: FG2A Ref document number: 2091251 Country of ref document: ES Kind code of ref document: T3 |
|
REG | Reference to a national code |
Ref country code: DK Ref legal event code: T3 |
|
PLBE | No opposition filed within time limit |
Free format text: ORIGINAL CODE: 0009261 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: NO OPPOSITION FILED WITHIN TIME LIMIT |
|
26N | No opposition filed | ||
REG | Reference to a national code |
Ref country code: GB Ref legal event code: IF02 |
|
REG | Reference to a national code |
Ref country code: GB Ref legal event code: 732E |
|
REG | Reference to a national code |
Ref country code: CH Ref legal event code: PUE Owner name: CHELATOR LLC Free format text: CONCAT LTD.#3205 NORTHWOOD DRIVE, SUITE 101#CONCORD, CA 94520 (US) -TRANSFER TO- CHELATOR LLC#3205 NORTHWOOD DRIVE SUITE 101#CONCORD/CA 94520 (US) |
|
NLS | Nl: assignments of ep-patents |
Owner name: CHELATOR LLC |
|
REG | Reference to a national code |
Ref country code: FR Ref legal event code: TP |
|
REG | Reference to a national code |
Ref country code: ES Ref legal event code: PC2A |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: NL Payment date: 20040929 Year of fee payment: 15 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: AT Payment date: 20041004 Year of fee payment: 15 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: GB Payment date: 20041013 Year of fee payment: 15 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: FR Payment date: 20041020 Year of fee payment: 15 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: DK Payment date: 20041021 Year of fee payment: 15 Ref country code: SE Payment date: 20041021 Year of fee payment: 15 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: LU Payment date: 20041027 Year of fee payment: 15 Ref country code: GR Payment date: 20041027 Year of fee payment: 15 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: CH Payment date: 20041029 Year of fee payment: 15 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: ES Payment date: 20041110 Year of fee payment: 15 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: BE Payment date: 20041125 Year of fee payment: 15 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: DE Payment date: 20041130 Year of fee payment: 15 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: IT Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES;WARNING: LAPSES OF ITALIAN PATENTS WITH EFFECTIVE DATE BEFORE 2007 MAY HAVE OCCURRED AT ANY TIME BEFORE 2007. THE CORRECT EFFECTIVE DATE MAY BE DIFFERENT FROM THE ONE RECORDED. Effective date: 20051017 Ref country code: AT Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20051017 Ref country code: GB Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20051017 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: SE Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20051018 Ref country code: ES Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20051018 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: BE Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20051031 Ref country code: LU Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20051031 Ref country code: CH Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20051031 Ref country code: LI Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20051031 Ref country code: DK Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20051031 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: NL Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20060501 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: DE Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20060503 |
|
REG | Reference to a national code |
Ref country code: DK Ref legal event code: EBP |
|
REG | Reference to a national code |
Ref country code: CH Ref legal event code: PL |
|
EUG | Se: european patent has lapsed | ||
GBPC | Gb: european patent ceased through non-payment of renewal fee |
Effective date: 20051017 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: FR Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20060630 |
|
NLV4 | Nl: lapsed or anulled due to non-payment of the annual fee |
Effective date: 20060501 |
|
REG | Reference to a national code |
Ref country code: FR Ref legal event code: ST Effective date: 20060630 |
|
REG | Reference to a national code |
Ref country code: ES Ref legal event code: FD2A Effective date: 20051018 |
|
BERE | Be: lapsed |
Owner name: *CHELATOR LLC Effective date: 20051031 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: GR Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 19960731 |